Literature DB >> 3003381

Human parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein: nucleotide sequence of mRNA and limited amino acid sequence of the purified protein.

N Elango, J E Coligan, R C Jambou, S Venkatesan.   

Abstract

The nucleotide sequence of mRNA for the hemagglutinin-neuraminidase (HN) protein of human parainfluenza type 3 virus obtained from the corresponding cDNA clone had a single long open reading frame encoding a putative protein of 64,254 daltons consisting of 572 amino acids. The deduced protein sequence was confirmed by limited N-terminal amino acid microsequencing of CNBr cleavage fragments of native HN that was purified by immunoprecipitation. The HN protein is moderately hydrophobic and has four potential sites (Asn-X-Ser/Thr) of N-glycosylation in the C-terminal half of the molecule. It is devoid of both the N-terminal signal sequence and the C-terminal membrane anchorage domain characteristic of the hemagglutinin of influenza virus and the fusion (F0) protein of the paramyxoviruses. Instead, it has a single prominent hydrophobic region capable of membrane insertion beginning at 32 residues from the N terminus. This N-terminal membrane insertion is similar to that of influenza virus neuraminidase and the recently reported structures of HN proteins of Sendai virus and simian virus 5.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003381      PMCID: PMC252760     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Sequence determination of the Sendai virus fusion protein gene.

Authors:  B M Blumberg; C Giorgi; K Rose; D Kolakofsky
Journal:  J Gen Virol       Date:  1985-02       Impact factor: 3.891

2.  Hemagglutinin-neuraminidase protein of the paramyxovirus simian virus 5: nucleotide sequence of the mRNA predicts an N-terminal membrane anchor.

Authors:  S W Hiebert; R G Paterson; R A Lamb
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

3.  Computer analysis of nucleic acids and proteins.

Authors:  C L Queen; L J Korn
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

4.  Structural characterization of virion proteins and genomic RNA of human parainfluenza virus 3.

Authors:  D G Storey; K Dimock; C Y Kang
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

5.  Radiochemical sequence analysis of biosynthetically labeled proteins.

Authors:  J E Coligan; F T Gates; E S Kimball; W L Maloy
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

7.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

8.  5'-Terminal sequences of eucaryotic mRNA can be cloned with high efficiency.

Authors:  H Land; M Grez; H Hauser; W Lindenmaier; G Schütz
Journal:  Nucleic Acids Res       Date:  1981-05-25       Impact factor: 16.971

9.  Proteolytic activation of the haemagglutinin-neuraminidase of Newcastle disease virus involves loss of a glycopeptide.

Authors:  W Garten; T Kohama; H D Klenk
Journal:  J Gen Virol       Date:  1980-11       Impact factor: 3.891

10.  Association of a new type of cytopathogenic myxovirus with infantile croup.

Authors:  R M CHANOCK
Journal:  J Exp Med       Date:  1956-10-01       Impact factor: 14.307

View more
  26 in total

1.  Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity.

Authors:  M K Spriggs; B R Murphy; G A Prince; R A Olmsted; P L Collins
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

2.  Properties of human parainfluenza virus type 3 RNA polymerase/replicase activity in vitro: consensus with other negative-stranded RNA viruses.

Authors:  A Moscona; R W Peluso
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Neutralization map of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition.

Authors:  R M Iorio; R J Syddall; J P Sheehan; M A Bratt; R L Glickman; A M Riel
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

4.  The haemagglutinin-neuraminidase glycoprotein of the porcine paramyxovirus LPMV: comparison with other paramyxoviruses revealed the closest relationship to simian virus 5 and mumps virus.

Authors:  A Sundqvist; M Berg; J Moreno-López; T Linné
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

5.  Sequence analysis of temperature sensitive and "neuraminidase-tolerant" mutants of Newcastle disease virus (strain Beaudette C).

Authors:  J Hughes; K Yusoff; R Hardy; H McCartney; P T Emmerson; A C Samson
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

6.  Antigenic and structural properties of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3: sequence analysis of variants selected with monoclonal antibodies which inhibit infectivity, hemagglutination, and neuraminidase activities.

Authors:  K L van Wyke Coelingh; C C Winter; E D Jorgensen; B R Murphy
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

7.  Conserved epitopes on the hemagglutinin-neuraminidase proteins of human and bovine parainfluenza type 3 viruses: nucleotide sequence analysis of variants selected with monoclonal antibodies.

Authors:  K J Coelingh; C C Winter; B R Murphy; J M Rice; P C Kimball; R A Olmsted; P L Collins
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

8.  O glycosylation of glycoprotein G of human respiratory syncytial virus is specified within the divergent ectodomain.

Authors:  P L Collins
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

9.  Characterization of an in vitro system for the synthesis of mRNA from human parainfluenza virus type 3.

Authors:  B P De; M S Galinski; A K Banerjee
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

10.  Processing, surface expression, and immunogenicity of carboxy-terminally truncated mutants of G protein of human respiratory syncytial virus.

Authors:  R A Olmsted; B R Murphy; L A Lawrence; N Elango; B Moss; P L Collins
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.